L. Uller (Lund, Sweden), C. Brightling (Leicester (Leicestershire), United Kingdom)
The potent and lung-selective inhaled pan JAK inhibitor TD-8236 limits airway inflammation without affecting systemic immunity in mice
A. Mcnamara (South San Francisco, United States of America), C. Campbell (South San Francisco, United States of America), A. Heinichen (South San Francisco, United States of America), E. Situ (South San Francisco, United States of America), W. Lee (South San Francisco, United States of America), E. Kaufman (South San Francisco, United States of America), P. Fatheree (South San Francisco, United States of America), M. Kleinschek (South San Francisco, United States of America)
|     |
Fevipiprant antagonises prostaglandin D2-induced activation of type-2 CD8 T cells (Tc2)
W. Chen (Oxford, United Kingdom), R. Borst (Oxford, United Kingdom), J. Luo (Oxford, United Kingdom), M. Chizari (Oxford, United Kingdom), L. Chocarro De Erauso (Oxford, United Kingdom), V. Erpenbeck (Basel, Switzerland), S. Kazani (Cambridge MA, United States of America), D. Sandham (Cambridge MA, United States of America), L. Xue (Oxford, United Kingdom)
| |
ICS/LABA effects on antiviral innate immune response. An in vitro analysis.
A. Marcellini (Ferrara, Italy), M. Contoli (Ferrara, Italy), P. Casolari (Ferrara, Italy), S. Johnston (London, United Kingdom), A. Papi (Ferrara, Italy), R. Solari (London, United Kingdom)
| |
An inhaled IGFBP-3 peptide attenuates steroid-resistant neutrophilic bronchial asthma through modulation of ER stress
S. Kim (Jeonju, Republic of Korea), Y. Lee (Jeonju, Republic of Korea), H. Park (Jeonju, Republic of Korea), K. Park (Jeonju, Republic of Korea)
| |
A novel role for TRPM3 in Airway Smooth Muscle Contraction
S. Bonvini (London, United Kingdom), J. Adcock (Gothenburg, Sweden), N. Kobold (London, United Kingdom), P. Phuah (London, United Kingdom), M. Birrell (Gothenburg, Sweden), M. Belvisi (Gothenburg, Sweden)
| |
BDNF-TrkB signaling mediates cholinergic neuroplasticity in asthma
G. Dragunas (Groningen, Netherlands), M. Woest (Groningen, Netherlands), S. Nijboer (Groningen, Netherlands), S. Bos (Groningen, Netherlands), C. Vermeulen (Groningen, Netherlands), B. Ditz (Groningen, Netherlands), J. Vonk (Groningen, Netherlands), G. Koppelman (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands), N. Ten Hacken (Groningen, Netherlands), W. Timens (Groningen, Netherlands), C. Munhoz (São Paulo, Brazil), Y. Prakash (Rochester, United States of America), R. Gosens (Groningen, Netherlands), L. Kistemaker (Groningen, Netherlands)
| |
Therapeutic effects of topical calcilytic in IgE/Th2 and alarmin-driven surrogates of human asthma
P. Huang (Cardiff, United Kingdom), B. Mansfield (Cardiff, United Kingdom), X. Du (Beijing, China), Q. Huang (Beijing, China), W. Wang (Beijing, China), F. William (Cardiff, United Kingdom), E. Kidd (Cardiff, United Kingdom), C. Corrigan (London, United Kingdom), J. Ward (London, United Kingdom), P. Kemp (Cardiff, United Kingdom), Y. Sun (Beijing, China), D. Riccardi (Cardiff, United Kingdom)
| |